Key result
Benzamides and isoindolines were identified as potent PLpro inhibitors that successfully inhibited SARS-CoV-2 replication in cell culture.
Why the study?
Inhibition of coronavirus-encoded papain-like cysteine proteases represents an attractive strategy to treat infections caused by these pathogens.
Benzamides and isoindolines are potent PLpro inhibitors that inhibit SARS-CoV-2 replication in cell culture, providing a basis for pan-coronaviral inhibitor development.
Inhibition of coronavirus (CoV)‐encoded papain‐like cysteine proteases (PLpro) represents an attractive strategy to treat infections by these important human pathogens. Herein we report on structure‐activity relationships (SAR) of the noncovalent active‐site directed inhibitor (R)‐5‐amino‐2‐methyl‐N‐(1‐(naphthalen‐1‐yl)ethyl) benzamide (2 b), which is known to bind into the S3 and S4 pockets of the SARS‐CoV PLpro. Moreover, we report the discovery of isoindolines as a new class of potent PLpro inhibitors. The studies also provide a deeper understanding of the binding modes of this inhibitor class. Importantly, the inhibitors were also confirmed to inhibit SARS‐CoV‐2 replication in cell culture suggesting that, due to the high structural similarities of the target proteases, inhibitors identified against SARS‐CoV PLpro are valuable starting points for the development of new pan‐coronaviral inhibitors.
No takes yet. Share an insight, caveat, or question.
Welker et al. (2020) studied SARS-CoV and SARS-CoV-2 infection. Benzamides and isoindolines (PLpro inhibitors) was evaluated on Inhibition of SARS-CoV-2 replication in cell culture. Benzamides and isoindolines were identified as potent PLpro inhibitors that successfully inhibited SARS-CoV-2 replication in cell culture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: